These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 39018867

  • 61. Treatment options for recurrent giant cell tumors of bone.
    Balke M, Ahrens H, Streitbuerger A, Koehler G, Winkelmann W, Gosheger G, Hardes J.
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
    [Abstract] [Full Text] [Related]

  • 62. Denosumab for Bone Giant Cell Tumor of the Distal Radius.
    Tsukamoto S, Mavrogenis AF, Tanzi P, Leone G, Ciani G, Righi A, Akahane M, Honoki K, Tanaka Y, Donati DM, Errani C.
    Orthopedics; 2020 Sep 01; 43(5):284-291. PubMed ID: 32745221
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Osteosarcoma of the pelvis. Oncologic results of 40 patients.
    Kawai A, Huvos AG, Meyers PA, Healey JH.
    Clin Orthop Relat Res; 1998 Mar 01; (348):196-207. PubMed ID: 9553553
    [Abstract] [Full Text] [Related]

  • 66. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pieńkowski A, Grimer R.
    Eur J Surg Oncol; 2018 Sep 01; 44(9):1384-1390. PubMed ID: 29650420
    [Abstract] [Full Text] [Related]

  • 67. Autologous Platelet Gel Improves Bone Reconstruction of Large Defects in Patients with Bone Giant Cell Tumors.
    Loquercio G, DI Costanzo G, Fazioli F, Gallo M, DE Chiara A, Iervolino V, Azzaro R, Petruzziello A, Mattiello A, Cacciapuoti C.
    In Vivo; 2015 Sep 01; 29(5):533-40. PubMed ID: 26359411
    [Abstract] [Full Text] [Related]

  • 68. Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement.
    Gao ZH, Yin JQ, Xie XB, Zou CY, Huang G, Wang J, Shen JN.
    BMC Musculoskelet Disord; 2014 Oct 02; 15():330. PubMed ID: 25277133
    [Abstract] [Full Text] [Related]

  • 69. May bone cement be used to treat benign aggressive bone tumors of the feet with confidence?
    Özer D, Er T, Aycan OE, Öke R, Coşkun M, Kabukçuoğlu YS.
    Foot (Edinb); 2014 Mar 02; 24(1):1-5. PubMed ID: 24365067
    [Abstract] [Full Text] [Related]

  • 70. In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage.
    Chen L, Ding XY, Wang CS, Si MJ, Du LJ, Zhang WB, Lu Y.
    Radiol Med; 2014 Nov 02; 119(11):861-70. PubMed ID: 24604549
    [Abstract] [Full Text] [Related]

  • 71. Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update.
    Tsukamoto S, Mavrogenis AF, Masunaga T, Honoki K, Fujii H, Kido A, Tanaka Y, Errani C.
    Curr Oncol; 2024 Apr 08; 31(4):2112-2132. PubMed ID: 38668060
    [Abstract] [Full Text] [Related]

  • 72. Utility of intraoperative magnetic resonance imaging for giant cell tumor of bone after denosumab treatment: a pilot study.
    Furuta T, Kubo T, Sakuda T, Saito T, Kurisu K, Muragaki Y, Adachi N.
    Acta Radiol; 2022 Feb 08; 63(2):176-181. PubMed ID: 33517664
    [Abstract] [Full Text] [Related]

  • 73. [Allogeneic bone transplantation for pelvic reconstruction of large skeletal defects after tumor resection].
    Wang W, Wang Y, Bi W, Yang J, Han G, Ia J, Xu M, Liu G.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Mar 08; 28(3):331-4. PubMed ID: 24844014
    [Abstract] [Full Text] [Related]

  • 74. Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?
    van der Heijden L, van de Sande MA, Heineken AC, Fiocco M, Nelissen RG, Dijkstra PD.
    J Bone Joint Surg Am; 2013 Nov 06; 95(21):e159. PubMed ID: 24196471
    [Abstract] [Full Text] [Related]

  • 75. Decision making in primary sacral tumors.
    Puri A, Agarwal MG, Shah M, Srinivas CH, Shukla PJ, Shrikhande SV, Jambhekar NA.
    Spine J; 2009 May 06; 9(5):396-403. PubMed ID: 19059810
    [Abstract] [Full Text] [Related]

  • 76. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
    Puri A, Gulia A, Hegde P, Verma V, Rekhi B.
    Bone Joint J; 2019 Feb 06; 101-B(2):170-177. PubMed ID: 30700112
    [Abstract] [Full Text] [Related]

  • 77. Curettage and radiotherapy of giant cell tumour of the sacrum: a case report with a 10-year follow-up.
    Kanamori M, Ohmori K.
    J Orthop Surg (Hong Kong); 2005 Aug 06; 13(2):171-3. PubMed ID: 16131681
    [Abstract] [Full Text] [Related]

  • 78. Treatment of giant cell tumors in the sacrum and spine with curettage and argon beam coagulator.
    Takeda N, Kobayashi T, Tandai S, Matsuno T, Shirado O, Watanabe T, Minami A.
    J Orthop Sci; 2009 Mar 06; 14(2):210-4. PubMed ID: 19337814
    [No Abstract] [Full Text] [Related]

  • 79. Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor.
    Ruggieri P, Mavrogenis AF, Ussia G, Angelini A, Papagelopoulos PJ, Mercuri M.
    Clin Orthop Relat Res; 2010 Nov 06; 468(11):2954-61. PubMed ID: 20623262
    [Abstract] [Full Text] [Related]

  • 80. [Treatment of Giant Cell Tumor of Bone in the Distal Radius and Ulna].
    Mahdal M, Jindra J, Staniczková Zambo I, Pazourek L, Nachtnebl L, Tomáš T.
    Acta Chir Orthop Traumatol Cech; 2022 Nov 06; 89(3):188-192. PubMed ID: 35815484
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.